jump to navigation

MBBP’s Life Sciences Vector Newsletter, Summer 2017 08/24/2017

Posted by Morse Barnes-Brown Pendleton in Client News.
Tags: , , , , , , ,
add a comment

extOur Life Sciences team has published the Summer 2017 edition of its Vector newsletter. Below you will find brief descriptions of the news and articles included in the publication. Read the full newsletter for more information.

CORPORATE PARTNER MIKE JABBAWY PARTICIPATING ON SHOOBX STARTUP PANEL

On September 26, corporate partner Mike Jabbawy will take part in the panel “How to Start a Startup.” The panel is part of Shoobx’s Startup Series, which features real life stories from startup founders, investors, and community members. More information and how to register for the event can be found on page 1.

INTELLECTUAL PROPERTY ATTORNEY AMANDA SCHREYER JOINS MBBP AS COUNSEL

Intellectual Property attorney Amanda Schreyer joined the firm as Counsel. Amanda focuses her practice on licensing and strategic alliances; trademarks and copyrights; and privacy and data security. Read more about Amanda’s practice.

MORE MONEY FOR LIFE SCIENCES?

A new legislative proposal to provide a five-year, $500 million life sciences initiative was recently announced by Governor Charlie Baker. This initiative would extend the current 10-year, $1 billion initiative that is set to expire at the end of the next fiscal year and would continue to be managed by the Massachusetts Life Sciences Center. More information about the proposal can be found on page 1.

SANDOZ INC. v. AMGEN INC.: SUPREME COURT CLARIFIES BPCIA PROVISIONS

On June 12, 2017, the United States Supreme Court issued its first ruling on two key provisions of the Biologics Price Competition and Innovation Act (“BPCIA”) concerning the resolution of patent infringement suits in connection with the submission to the Food and Drug Administration (“FDA”) of applications to commercialize biosimilars in the United States. Read more about the case implications.

LIFE TECHNOLOGIES CORP. v. PROMEGA CORP.

On February 22, 2017, the Supreme Court issued its decision in Life Technologies Corp. v. Promega Corp., a case focused on interpreting the patent infringement statute which creates liability for exporting a component of a patented invention. Read the full article for more information.

TC HEARTLAND LCC v. KRAFT FOODS GROUP BRANDS LLC

In TC Heartland LLC v. Kraft Foods Group Brands LLC, the Supreme Court unanimously held that 28 U.S.C. § 1400(b) is the exclusive provision controlling venue in patent cases, and that under this provision a corporation “resides” only in the state of incorporation. Continue reading for more information about the case.

THE MINUTIAE OF CORPORATE MINUTES?

Young entrepreneurs and corporate associates of emerging companies frequently ask: “How detailed should Board of Directors meetings’ minutes be?” The short answer is: Do not delve into minutiae, other than precision for approval of equity issuances, option grants and material contracts. More guidance on corporate minutes can be found starting on page 4.

CLIENT SPOTLIGHT: CRISTCOT LLC

Cristcot LLC is a global life sciences company focused on the development and commercialization of unique drug delivery systems, combination products, and specialty drug formulations that improve the quality of patient care. Read the full spotlight on page 6.

Encore Event! Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series, June 28 06/05/2017

Posted by Morse Barnes-Brown Pendleton in Attorney News, Corporate, Events, Life Sciences, MBBP news.
Tags: , , , ,
add a comment

JMH Headshot Photo 2015 (M0846571xB1386)Due to overwhelming demand for our April 28 “Strategic Alliances: Pot of Gold or Pretty Poison?” event, we will be holding another round on Wednesday, June 28 at the Cambridge Innovation Center (CIC). Moderated by corporate attorney John Hession, a panel of business development experts will explore various research and collaboration structures, from options to license to comprehensive collaboration partnerships. The panel will discuss various licensing vehicles, the importance of concise fields of use descriptions, sample economics, and conventional transaction structures.

Space is limited! View our event page for more information and to register for the event.

Strategic Alliances: Pot of Gold or Pretty Poison? – Life Sciences Series Panel 4 Event, April 28 04/11/2017

Posted by Morse Barnes-Brown Pendleton in Attorney News, Corporate, Events, Licensing & Strategic Alliances, Life Sciences, MBBP news.
Tags: , , , , ,
add a comment

JMH Headshot Photo 2015 (M0846571xB1386)Our Life Sciences Series Panel 4 event, Strategic Alliances: Pot of Gold or Pretty Poison?, will be held on Friday, April 28 from 7:30-10am in our Waltham office. Moderated by corporate attorney John Hession, a panel of business development experts from Big Pharma and Small Biotech explore various research and collaboration structures, from options to license to comprehensive collaboration partnerships. We will discuss various licensing vehicles, the importance of concise fields of use descriptions, sample economics, and conventional transaction structures.

View our event page for more information and to register for the event.

%d bloggers like this: